Close Menu

NEW YORK – Roche on Thursday reported a 3 percent decline in half-year revenues for its Diagnostics division. At constant exchange rates, however, diagnostics revenues were up 3 percent, and the main driver of both revenue gains and misses was the COVID-19 pandemic.

For the first half of 2020, the Roche Group reported CHF 29.28 billion ($31.53 billion) in total sales, down 4 percent (up 1 percent at constant exchange rates) from CHF 30.47 billion during the first half of 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.